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ORIGINAL ARTICLE
Salivary cytokine levels in early gingival inflammation
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Copenhagen, Copenhagen, Denmark; bInstitute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet,
Copenhagen University Hospital, Copenhagen, Denmark; cDepartment of Periodontology, Institute of Dentistry, University of Turku,
Turku, Finland
ABSTRACT
Salivary protein levels have been studied in periodontitis. However, there is lack of informa-
tion on salivary cytokine levels in early gingival inflammation. The aim of this study was to
determine salivary levels of vascular endothelial growth factor (VEGF), interleukin (IL)-8,
monocyte chemoattractant protein (MCP)-1, IL-1β, and IL-1 receptor antagonist (IL-1Ra) in
gingival inflammation. Twenty-eight systemically and orally healthy nonsmokers abstained
from oral hygiene protocols for 10 days. After that, self-performed cleaning was resumed for
14 days. Plaque and gingival indexes were measured, and saliva samples were collected at
days 1, 4, 7, 10, and 24. Salivary cytokines were detected with Luminex®-xMAP™. Salivary IL-
1β, IL-1Ra, and VEGF levels decreased after 10 days’ development of experimental gingivitis
and reached baseline levels at the end of the 2-week resolution period. Salivary IL-8 levels
decreased and remained low during development and resolution of experimental gingivitis.
Initial inflammation in gingival tissues is associated with a decrease in inflammatory cytokines
in saliva. Further studies are needed to evaluate if inflammatory cytokines bind to their
functional receptors within the gingival tissue during early gingivitis, which may limits their
spillover to the gingival crevice and ultimately saliva.
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Introduction
Gingivitis is the inflammatory gingival response
against excessive bacterial biofilms [1]. It is a rever-
sible condition. However, if left undisturbed, the gin-
gival inflammation becomes chronic and may
ultimately lead to periodontitis, with degradation of
the tooth-supporting tissues.
Early detection of inflammatory changes in the
gingival tissues has major significance for the treat-
ment and prognosis of periodontal diseases. While
gingivitis is easily reversed in healthy individuals,
the risk of disease progression to periodontitis in
susceptible individuals is substantial. At present, the
diagnosis of gingivitis relies on clinical signs of gin-
gival inflammation (i.e. gingival edema, bleeding on
probing, and increased crevicular fluid) the latter of
which spill over to the saliva. Based on its content of
various biological substances, saliva may possess the
potential to serve as a diagnostic tool for oral diseases
[2]. Several salivary proteins, such as interleukin (IL)-
1β, matrix metalloproteinase (MMP)-8, and pyridino-
line cross-linked carboxyterminal telopeptide of type
I collagen (ICTP), have successfully been used in
screening for periodontal disease activity [3,4].
However, as these proteins are associated with
extensive collagen degradation and osteoclast activa-
tion [5,6], they do not reflect the initiation of
gingivitis.
At the molecular level, initiation and resolution of
gingival inflammation are regulated by host chemo-
kines, cytokines, and to some extent pro-resolving
lipid mediators [7]. The initial steps in this inflam-
matory process are increased blood flow and vascu-
larization (angiogenesis), increased vascular
permeability, and migration of neutrophils and
monocytes/macrophages to the site of infection [6].
The hypothesis for this study was that early-stage
gingivitis impacts salivary levels of specific chemo-
kines and cytokines. Thus, the aim was to quantify
selected chemokines and cytokines associated with
early stages of gingivitis (i.e. vascular endothelial
growth factor [VEGF], IL-8, monocyte chemoattrac-
tant protein [MCP-1], IL-1β, and IL-1 receptor
antagonist [IL-1Ra]).
Materials and methods
Study population and its selection criteria
A total of 31 dental students from the University of
Copenhagen were enrolled. The recruitment protocol
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was based on the following selection criteria: systemi-
cally and orally healthy nonsmokers aged ≥18 years
who were willing to discontinue brushing their teeth
and interdental cleaning for 10 days. All subjects with
active caries lesions, gingivitis or periodontitis, hypo-
salivation, any prescribed medication within the pre-
vious 3 months, including antibiotics and/or
professional dental cleaning, were excluded. The
volunteers were informed about the objectives of
this experiment prior to obtaining their written con-
sent. The study was approved by the regional ethical
committee of the Capital Region of Denmark (H-
16016368–56386) and complied with the
Declaration of Helsinki. Furthermore, it was reported
to the Danish Data Authority (SUND-2016–58) and
registered at clinicaltrials.gov (NCT02913235).
Study design and clinical recordings
Oral health status was screened full-mouth and by use
of bitewings radiographs. The total duration of this
study was 24 days, out of which participants stopped
all oral hygiene protocols for 10 days. Regular oral
hygiene was then resumed for 14 days. Gingival exam-
inations, including registrations of plaque and gingival
inflammation, were performed at baseline and at days
4, 7, 10, and 24 by the same examiner (DB). Plaque
index (PI) and gingival index (GI) were recorded and
calculated based on four sites (buccal, lingual, mesial,
and distal) of six preselected teeth (16, 12, 24, 44, 32,
and 36) as previously described [8,9].
Saliva sampling
Stimulated saliva samples were collected, as pre-
viously described [10]. At each visit, the samples
were collected from the study population by the
same examiner (DB) between 8:00am and 6:00pm.
Great care was taken that all saliva sampling per
subject was performed at the same time of the day.
In brief, participants were instructed to avoid eating
and drinking for at least 2 h before sampling.
Chewing a sterile paraffin gum was used to stimulate
saliva secretion, and participants spat into a sterile
plastic cup until 1 mL of sample material was col-
lected. Saliva samples were then divided into two
aliquots and immediately placed on dry ice. Samples
were stored at −80°C until further analysis.
Analysis of salivary biomarkers
After thawing, all saliva samples were centrifuged at
9300 g for 5 min. In salivary assays, the supernatant
was used. Salivary concentrations of VEGF, IL-8, MCP-
1, IL-1β, and IL-1Ra were detected by the Luminex®
xMAP™ technique (Luminex Corporation, Austin, TX)
with the commercially optimized Bio-Plex kits (pro-
human cytokine group I assays; Bio-Rad, Santa Rosa,
CA) according to the manufacturer’s instructions. The
detection limit of the assay was 3.1 pg/mL for VEGF,
1.0 pg/mL for IL-8, 1.1 pg/mL for MCP-1, 0.6 pg/mL for
IL-1β, and 5.5 pg/mL for IL-1Ra.
Statistical analyses
All data were checked for normal distribution. Data
following a Gaussian distribution were compared
using repeated measures of analysis of variance and
repeated t-test, whereas nonparametric data were
analyzed with Friedman’s test with Dunn’s multiple
comparison tests. p-Values <0.05 were considered
statistically significant. Correlations between cyto-
kines were computed using Spearman’s signed rank
test and corrected for multiple dependent compari-
sons. GraphPad Prism v5 (GraphPad Software, Inc.,
La Jolla, CA) was used as statistical software.
Results
Out of 31 recruited subjects, 29 (95.3%) completed
the study. The mean age of the participants was
24.7 years (range 22–29 years), and the majority
(82.8%) were female. The reason for the two dropouts
was the use of antibiotics prescribed for bacterial
infection unrelated to the oral cavity. Furthermore,
as one saliva sample tube broke during centrifuga-
tion, the remaining samples from that participant
were discarded. Consequently, samples from 28 par-
ticipants were included in further analyses.
Clinical data
PI and GI values increased significantly during the
experimental gingivitis period (at days, 4, 7, and 10).
After 2 weeks of resolution (day 24), PI and GI scores
were not significantly different from baseline scores
(Figure 1).
Early gingivitis impacts levels of salivary
cytokines
In all samples, salivary concentrations of tested
cytokines were above the detection limits of the
test kit. Salivary levels of IL-1β, IL-1Ra, IL-8,
MCP-1, and VEGF are presented in Figure 2.
Salivary IL-1β, IL-1Ra, and VEGF were all signifi-
cantly reduced after 10 days (p < 0.05) compared to
baseline, whereas MCP-1 levels were reduced at day
4 and day 7, respectively (p < 0.05). Salivary IL-8
was significantly reduced at day 4 and stayed low,
even after resolution of experimental gingivitis
(p < 0.05; Figure 2).
2 D. BELSTRØM ET AL.
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Correlation of salivary cytokines
Correlation of baseline concentrations and levels
recorded at days 4, 7, 10, and 24 of each cytokine is
presented in Table 1. A strong correlation was
observed between baseline samples and samples col-
lected 14 days after resolution of experimental gingi-
vitis (day 24) of IL-1β (R = 0.66, p < 0.001), IL-1Ra
(R = 0.85, p < 0.001), IL-8 (R = 0.79, p < 0.001), and
VEGF (R = 0.80, p < 0.001).
Correlation between salivary IL-1β, IL-1Ra, IL-8,
MCP-1, and VEGF is detailed in Table 2. While
highly significant correlations were observed between
salivary levels of all cytokines investigated, the stron-
gest correlations were observed between IL-1β and
IL-8 (R = 0.86) and IL-1Ra and VEGF (R = 0.92).
No significant correlation was observed at the
individual level between clinical parameters (PI and
GI) and salivary levels of IL-1β, IL-1Ra, IL-8, MCP-1,
and VEGF (p > 0.05).
Figure 1. Clinical data. (a) Dot-plot of plaque index (PI) recorded at baseline and at days 4, 7, 10, and 24. (b) Dot-plot of gingival
index (GI) recorded at baseline and at days 4, 7, 10, and 24. Horizontal lines: median value. **p < 0.01; ***p < 0.0001.
Figure 2. Salivary levels of interleukin (IL)-1β, IL-1Ra, IL-8, monocyte chemoattractant protein (MCP-1), and vascular endothelial
growth factor (VEGF). Dot-plot of salivary levels of IL-1β, IL-1Ra, IL-8, MCP-1, and VEGF recorded at baseline and at days 4, 7, 10,
and 24. Horizontal lines: median value. *p < 0.05.
Table 1. Correlation coefficients (R) for salivary IL-1β, IL-1Ra,
IL-8, MCP-1, and VEGF levels between the visits at baseline
and at day 4, 7, 10, and 24
Baseline vs.
day 4
Baseline vs.
day 7
Baseline vs.
day 10
Baseline vs.
day 24
IL-1β 0.33 0.45* 0.38 0.66**
IL-1Ra 0.38 0.37 0.44* 0.85**
IL-8 0.48* 0.46* 0.53* 0.79**
MCP-1 0.63** 0.50* 0.68** 0.40*
VEGF 0.40* 0.40* 0.54* 0.80**
*p < 0.05; **p < 0.01.
IL, interleukin; IL-Ra, IL-1 receptor antagonist; MCP-1, monocyte che-
moattractant protein; VEGF, vascular endothelial growth factor.
Table 2. Correlation coefficients (R) between salivary levels of
IL-1β, IL1-Ra, IL-8, MCP-1, and VEGF
IL-1Ra IL-8 MCP-1 VEGF
IL-1β 0.78*** 0.86*** 0.48*** 0.78***
IL-1Ra 0.73*** 0.58*** 0.92***
IL-8 0.49*** 0.76***
MCP-1 0.62***
***p < 0.0001.
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Discussion
The purpose of the present investigation was to char-
acterize salivary levels of five selected inflammatory
cytokines associated with gingivitis in order to test
the hypothesis that early-stage gingival inflammation
impacts salivary concentrations of specific cytokines.
The main finding was that early-stage experimental
gingivitis was associated with a significant decrease in
salivary concentrations of all cytokines investigated.
Salivary levels of the cytokines tested were altered
at different time points. MCP-1 and IL-8 were sig-
nificantly decreased already at day 4, whereas VEGF,
IL-1β, and IL-1Ra were significantly decreased after
10 days of oral hygiene discontinuation compared to
baseline levels. These findings probably reflect the
different roles of the chemokines and cytokines inves-
tigated in early inflammation. IL-8 and MCP-1 are
chemoattractants, which promote the migration of
neutrophils and monocytes/macrophages to the site
of the infectious challenge [11–13]. Thus, the signifi-
cant decrease in IL-8 and MCP-1 at day 4 is consis-
tent with the clinical recordings, which showed
moderate plaque formation but minimal signs of
gingival inflammation. On the contrary, VEGF and
IL-1β are cytokines that orchestrate inflammatory
changes of the gingival tissues such as angiogenesis
and edema [14–16]. It is therefore interesting that
VEGF and IL-1β were not significantly decreased
until 10 days after oral hygiene discontinuation,
when the majority of the participants had developed
moderate to severe gingivitis.
Other experimental gingivitis studies have demon-
strated decreased or steady gingival crevicular fluid IL-
8 levels [11,13], which is consistent with data from the
present investigation. On the other hand, elevated IL-
1β, steady IL-1Ra, and decreased MCP-1 levels have
been observed in gingival crevicular fluid samples in
experimental gingivitis [17–19], which conflicts with
data from this report. Furthermore, in one investiga-
tion, salivary IL-1Ra levels were found to be associated
with increased pocket-depth measurements in an
experimental gingivitis model, while no association
was observed between IL-1Ra and PI or GI [20].
These discrepancies might reflect differences between
studies in terms of sample material used (saliva vs.
crevicular fluid) and duration of the experimental gin-
givitis protocol (10 vs. 21 days). Notably, the disconti-
nuation of oral hygiene employed in this investigation
lasted only 10 days, and data suggest that in the initial
phases of inflammation, preserved gingival tissue integ-
rity supports the binding of the chemokines and cyto-
kines investigated to limit their release into gingival
crevicular fluid and saliva.
Major intra-individual differences in salivary levels
of each cytokine were noted. This finding probably
reflects the fact that while some individuals developed
pronounced generalized gingivitis, others only showed
modest clinical signs of gingival inflammation during
the 10-day period of oral hygiene cessation. This is
consistent with clinical data from other experimental
gingivitis studies in which substantial variations in
gingival inflammation were also recorded [11,21,22].
However, a good correlation between salivary levels of
each cytokine recorded suggests their possible use in
screening for early signs of gingival inflammation.
Obviously, this is especially relevant in individuals sus-
ceptible to periodontitis.
Some potential limitations apply to the results of this
study. Stimulated saliva samples were used for cytokine
analysis, which means that salivary levels of the cyto-
kines investigated were possibly diluted as a conse-
quence of the sampling strategy [23]. However,
salivary levels of each cytokine were above the detec-
tion level in all samples. Collection of unstimulated
saliva samples might be influenced by tongue and
cheek movements, which may impact salivary secretion
and protein concentration between subjects.
Consequently, stimulated saliva samples are suggested
as a valid alternative to unstimulated saliva samples
[24]. Partial recordings were used for calculation of PI
and GI, which may have influenced correlation analysis
between clinical parameters and salivary cytokine
levels. Thus, future experimental gingivitis studies
could employ full-mouth registration of plaque accu-
mulation and gingival inflammation.
In conclusion, salivary levels of inflammatory che-
mokines and cytokines were significantly decreased
during initiation and development of gingivitis.
Preserved gingival tissue integrity at early phases of
gingivitis may explain why pro-inflammatory cyto-
kines are not released into gingival crevicular fluid
and saliva. Further studies in susceptible groups,
including smokers, diabetics, and patients with
aggressive forms of periodontitis, are needed to eval-
uate the potential of salivary concentrations of
inflammatory cytokines to be used for screening of
early signs of gingival inflammation.
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